Indo Rama Synthetics (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
INDORAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Rama Synthetics reported strong Q1 FY26 results (quarter ended June 30, 2025), with consolidated revenue from operations rising to ₹1,305.71 Cr from ₹944.30 Cr a year ago, a growth of about 38%. Consolidated total income stood at ₹1,308.56 Cr versus ₹945.40 Cr. EBITDA jumped sharply to ₹100.27 Cr from ₹30.05 Cr, driven by higher volumes and better product mix. The company swung back to a consolidated profit after tax of ₹52.75 Cr, compared with a loss of ₹19.18 Cr in Q1 FY25. On a standalone basis, revenue grew to ₹1,184.94 Cr and PAT came in at ₹32.31 Cr versus a loss earlier. The statutory auditor, S S Kothari Mehta & Co. LLP, issued an unmodified (clean) limited review opinion on both standalone and consolidated results. The Board noted that the previous auditors had handled the Q1 FY24 review and FY25 audit, indicating a change of auditor for the current period.
A clear operational turnaround — both revenue and profitability have improved sharply year-on-year, which is likely to be viewed positively by investors. However, the change in statutory auditor mid-cycle is worth noting as a governance event to monitor.